[Cerebral and peripheral L-dopa uptake in patients with parkinsonian, depressive or manic syndromes administered L-dopa by perfusion combined or not with a decarboxylase inhibitor. Pharmacological effects].
作者信息
Geissbuhler F, Eisenring J J, Friedli P, Bartholini G, Tissot R
出版信息
Encephale. 1972 Mar-Apr;61(2):127-48.
PMID:4634903
Abstract
摘要
相似文献
1
[Cerebral and peripheral L-dopa uptake in patients with parkinsonian, depressive or manic syndromes administered L-dopa by perfusion combined or not with a decarboxylase inhibitor. Pharmacological effects].[帕金森综合征、抑郁或躁狂综合征患者通过灌注给予左旋多巴（联合或不联合脱羧酶抑制剂）时脑和外周左旋多巴摄取情况。药理作用]
Encephale. 1972 Mar-Apr;61(2):127-48.
2
3
L-DOPA, catecholamines, and behavior: a clinical and biochemical study in depressed patients.左旋多巴、儿茶酚胺与行为：抑郁症患者的临床与生化研究
Biol Psychiatry. 1970 Oct;2(4):341-66.
4
[Cerebral and peripheral consumption of L-5-HTP in patients with manic, depressive or psychotic syndromes].
Encephale. 1973 Sep-Oct;62(5):395-407.
5
6
[Substitutive therapy in Parkinson's syndromes. L-dopa plus peripheral decarboxylase inhibitor or 3-0-methyl dopa?].
Presse Med (1893). 1971 Jan 16;79(3):91-2.
7
8
Peripheral aromatic L-amino acids decarboxylase inhibitor in Parkinsonism. I. Effect on O-methylated metabolites of L-dopa-2- 14 C.帕金森病中的外周芳香族L-氨基酸脱羧酶抑制剂。I. 对L-多巴-2-¹⁴C的O-甲基化代谢产物的影响
J Clin Invest. 1972 Feb;51(2):452-5. doi: 10.1172/JCI106831.
9
[Therapy of Parkinson's syndrome with L-dopa and a decarboxylase inhibitor (Ro 4-4602). Course in 71 patients].[左旋多巴与脱羧酶抑制剂（Ro 4-4602）治疗帕金森综合征。71例患者的病程]
Schweiz Med Wochenschr. 1972 Jan 22;102(3):88-94.
10
[L-dopa therapy of Parkinson's syndrome. Comparison of pure L-dopa and the combination preparation L-dopa and decarboxylase inhibitor].
Dtsch Med Wochenschr. 1972 Aug 25;97(34):1246-8. doi: 10.1055/s-0028-1107539.
Zotero 插件